-
TRANSITION-LEVEL UTILITY IMPLICATIONS OF THE 2026 UK EQ-5D-5L VALUE SET: A COMPLETE HEALTH-STATE ANALYSIS
Aug 11, 2026, 17:16 PM -
KEY CONSIDERATIONS FOR THE DEVELOPMENT OF A NICE REFERENCE CASE EXTENSION IN MENTAL HEALTH DISORDERS
Aug 11, 2026, 17:16 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO COST-UTILITY ANALYSIS: A PROOF-OF-CONCEPT APPLICATION IN SEVERE ASTHMA BIOLOGICS
Aug 11, 2026, 17:16 PM -
CONFIRM, COMPLEMENT, CONTEXTUALIZE, THE 3CS OF RWE: HOW REAL-WORLD-EVIDENCE CAN SUPPORT ACCESS DECISIONS FOR NEW MEDICINES
Aug 11, 2026, 17:16 PM -
OBLIGATIONS WITHOUT REMEDIES? APPEAL AND REVIEW PATHWAYS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
FROM HEALTH TECHNOLOGY ASSESSMENT TO CLINICAL GUIDELINES: APPLICABILITY OF THE NICE SEVERITY MODIFIER
Aug 11, 2026, 17:16 PM -
CONGENITAL MALFORMATIONS AMONG NEWBORNS EXPOSED IN UTERO TO DIFFERENT ANTIDEPRESSANT CLASSES DURING PREGNANCY: A DESCRIPTIVE REAL-WORLD ANALYSIS OF ELECTRONIC MEDICAL RECORDS
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN AND SOCIAL IMPACT OF INNOVATIVE HER2-TARGETED THERAPIES IN HER2-POSITIVE BREAST CANCER: APREVALENCE-BASED COST-OF-ILLNESS AND SOCIAL VALUE ANALYSIS IN ALGERIA
Aug 11, 2026, 17:16 PM -
USE OF DISEASE-SPECIFIC EORTC SCALES IN SMOLDERING MULTIPLE MYELOMA: EVIDENCE FROM PATIENT INTERVIEWS AND ALIGNMENT WITH THE EORTC ITEM LIBRARY STRATEGY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND VALUE-BASED PRICE OF CT-152 FOR MAJOR DEPRESSIVE DISORDER IN JAPAN: A MARKOV MODEL ANALYSIS
Aug 11, 2026, 17:16 PM -
A STANDARDS-BASED GOVERNANCE FRAMEWORK FOR ARTIFICIAL INTELLIGENCE ASSISTED SYSTEMATIC LITERATURE REVIEWS UNDER THE EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
CO-ADMINISTRATION OF COVID-19 AND INFLUENZA VACCINES AMONG OLDER ADULTS IN GERMANY: A RETROSPECTIVE ANALYSIS IN THE 2023-2024 SEASON
Aug 11, 2026, 17:16 PM -
PICO DIVERGENCE AND EVIDENCE FEASIBILITY IN EU JOINT CLINICAL ASSESSMENTS: INSIGHTS FROM PUBLISHED SCOPING EXERCISES AND THE FIRST TOVORAFENIB ASSESSMENT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND PRICING OF AI TECHNOLOGY FOR READING MAMMOGRAMS IN THE ENGLAND NHS BREAST SCREENING PROGRAM
Aug 11, 2026, 17:16 PM -
FIVE YEARS OF THE FIFARMA W.A.I.T. INDICATOR: A LONGITUDINAL ANALYSIS OF ONCOLOGY AND ORPHAN DRUG ACCESS IN LATIN AMERICA (2022-2026)
Aug 11, 2026, 17:16 PM -
RELEVANCE OF BLOCKBUSTERS FOR THE PHARMACEUTICAL INDUSTRY
Aug 11, 2026, 17:16 PM -
USING CROSS-VALIDATION TO ASSESS MODEL SUITABILITY FOR NEW DECISION PROBLEMS: A CASE STUDY IN PREDIABETES
Aug 11, 2026, 17:16 PM -
PAEDIATRIC LAIV VACCINATION IN AUSTRIA: A COST-MINIMISATION ANALYSIS OF SCALING COVERAGE AND REDUCING HEALTHCARE BURDEN
Aug 11, 2026, 17:16 PM -
PATIENT-REPORTED HEALTH-RELATED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS: BIOLOGIC VERSUS CONVENTIONAL DMARD THERAPY IN EGYPT
Aug 11, 2026, 17:16 PM -
MEDICINE-ACCESS PREFERENCES ACROSS COMMON COLD AND HYPERTENSION TREATMENT CONTEXTS IN CHINA: A WITHIN-SUBJECT DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM
